Pfizer adds to obesity bet with up to $2.1 billion deal to develop Chinese company's pill

Thread starter International: Top News And Analysis
Start date Dec 9, 2025

International: Top News And Analysis

Guest

Dec 9, 2025

The deal will help Pfizer beef up and diversify its obesity drug pipeline following its $10 billion acquisition of obesity biotech Metsera last month.

Continue reading...

You must log in or register to reply here.

Facebook X Bluesky LinkedIn Reddit Pinterest Tumblr WhatsApp Email Link

Thread Information

Title: Pfizer adds to obesity bet with up to $2.1 billion deal to develop Chinese company's pill

Prefix: N/A

Forum: World News

Start date: Dec 9, 2025

Last reply date: Dec 9, 2025

Replies: 0

Thread Tags

Thread statistics

Created: International: Top News And Analysis, Dec 9, 2025

Replies: 0

Views: 10

About Us

XenTR Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout.

Color picker

Search